Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking semaglutide a day early is unlikely to be harmful, but it does shift your injection schedule going forward, and doing it regularly can affect how evenly the medicine works across the week. Semaglutide is a prescription-only medicine — your prescriber sets your dose and timing, and they're the right person to ask about any change to your routine. That said, life happens, and understanding what's behind the advice helps you make a sensible call. The NHS medicines page for semaglutide notes that if you need to shift an injection day, a gap of at least two days between doses is generally acceptable, but it directs you to the Patient Information Leaflet for your specific product — and so do we.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's Thursday, your usual injection day is Friday, and you're heading away for the weekend. The pen is in the fridge, the sharps bin is right there, and you're wondering whether one day makes a difference. For most people in most weeks, shifting Wegovy by a single day does not create a safety problem. Semaglutide has a long half-life (roughly seven days) which means the medicine from your previous injection is still working steadily through your body. A 24-hour change in timing does not produce a sudden spike or a dangerous gap.
What it does do is move your schedule. If you inject Thursday this week, Thursday is now your day. Next week, injecting Friday again would put two doses six days apart on one side and eight apart on the other. Neither is a crisis, but drifting back and forth is worth avoiding if you can, because stable weekly intervals support consistent appetite suppression.
On Wegovy, the escalating dose schedule matters too. Each pen is calibrated for four weekly injections, and the transition from one dose to the next is timed by your prescriber to manage tolerability. Small timing shifts don't break that plan. Habitual ones can.
A one-off early injection, perhaps because you're travelling or simply lost track of which day it is, rarely needs any intervention beyond noting the new schedule. The situation that calls for more thought is when you find yourself regularly pulling doses forward (a day here, two days there) because you're experiencing more hunger or discomfort in the days before the next injection is due.
That pattern can mean a couple of things. It might reflect normal variation in how semaglutide's appetite effects tail off toward the end of the week, something many people notice as they find their rhythm on treatment. It can also be a signal worth raising with your prescriber: is the current dose still right for where you are in the titration schedule? Dose adjustments on semaglutide follow a structured escalation precisely because the right dose makes end-of-week hunger manageable without needing to move the goalposts, and you can browse semaglutide examples to get a clearer sense of how different people experience that escalation in practice.
Our clinical team at nume (sorry, at nume) reviews every repeat order before it's dispensed, which is exactly the moment to flag this kind of pattern. A prescriber who knows your full picture can respond to it properly. If you want background on how timing questions fit into the broader cost of ongoing treatment, the Wegovy pricing page covers what a clinically supervised private service typically includes across a full course.
The authoritative source for your specific product is always the Patient Information Leaflet inside the box. For Wegovy, the leaflet states that if you want to change your injection day, you can do so as long as your last injection was given at least two days earlier. After that change, stick to the new day. That two-day minimum is the practical guard against the nausea and gastrointestinal discomfort that come from dosing intervals that are too short.
Two days is not a green light to inject early whenever it's convenient. It's the lower boundary of what's considered acceptable when a genuine schedule change is needed. The top of that boundary (the longest gap you can leave) is set at no more than two weeks before restarting as if you were beginning treatment again, according to the electronic Medicines Compendium, which holds the full prescribing information for Wegovy.
For readers asking specifically about whether two days early is safe, or those who want to read through the full clinical picture on shifting Wegovy's injection day, there are dedicated pages covering those angles. The short version: the further you push from your scheduled day in either direction, the more care the adjustment deserves.
You've done it. The pen is used. The next step is straightforward: write down today's date as your new injection day and use that going forward. Don't correct back by injecting late next week to split the difference, that creates the same compressed-interval risk in reverse.
Watch for any increase in side effects over the next few days. Nausea is the most common response to a shorter dosing interval, and it usually settles within 24 to 48 hours. If it's severe, persistent, or accompanied by significant vomiting, contact your prescriber or your pharmacy's aftercare team. Severe or persistent stomach pain that moves toward the back is one of the symptoms the MHRA has specifically highlighted in its guidance on GLP-1 medicines, get medical advice promptly if that happens, rather than waiting it out.
If you're on treatment through nume, our prescribers are reachable seven days a week through priority aftercare. A quick message is better than guessing.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.